Abbott Laboratories logo

Abbott Laboratories (ABL)

Market Open
3 Dec, 15:30
XETRA XETRA
107. 80
-1.14
-1.05%
- Market Cap
36.49 P/E Ratio
2.2% Div Yield
869 Volume
4.44 Eps
108.94
Previous Close
Day Range
107.8 109.22
Year Range
104.08 134.14
Want to track ABL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 47 days

Summary

ABL trading today lower at €107.8, a decrease of 1.05% from yesterday's close, completing a monthly decrease of -2.9% or €3.22. Over the past 12 months, ABL stock lost -1.12%.
ABL pays dividends to its shareholders, with the most recent payment made on Nov 17, 2025. The next estimated payment will be in In 2 months on Feb 17, 2026 for a total of €0.59.
The last earnings report, released on Oct 15, 2025, missed the consensus estimates by -0.5%. On average, the company has fell short of earnings expectations by -0.17%, based on the last three reports. The next scheduled earnings report is due on Jan 21, 2026.
Abbott Laboratories has completed 8 stock splits, with the recent split occurring on Jan 02, 2013.
The company's stock is traded on 16 different exchanges and in various currencies, with the primary listing on NYSE (USD).

ABL Chart

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 day ago
Abbott issues US device correction for some glucose monitors over faulty readings risk

Abbott issues US device correction for some glucose monitors over faulty readings risk

Abbott Laboratories said on Monday it has begun a correction in the United States for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus glucose monitoring sensors after internal testing showed some units may report falsely low glucose readings.

Reuters | 1 week ago
Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

Why Abbott is paying $21 billion for Exact Sciences and its Cologuard cancer test

Abbott is getting into the cancer-testing game with its $21 billion acquisition of Cologuard test maker Exact Sciences.

Marketwatch | 2 weeks ago

Abbott Laboratories (ABL) FAQ

What is the stock price today?

The current price is €107.80.

On which exchange is it traded?

Abbott Laboratories is listed on NYSE.

What is its stock symbol?

The ticker symbol is ABL.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.2%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 1.5.

When is the next earnings date?

The next earnings report will release on Jan 21, 2026.

Has Abbott Laboratories ever had a stock split?

Abbott Laboratories had 8 splits and the recent split was on Jan 02, 2013.

Abbott Laboratories Profile

- Industry
- Sector
Robert B. Ford CEO
XETRA Exchange
US0028241000 ISIN
US Country
114,000 Employees
15 Oct 2025 Last Dividend
2 Jan 2013 Last Split
13 Jan 1978 IPO Date

Overview

Abbott Laboratories is a global healthcare company that engages in the discovery, development, manufacturing, and sale of a wide range of health care products. With its foundation laid in 1888, and headquartered in North Chicago, Illinois, the company has established a significant presence worldwide. Abbott operates across four main sectors: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices, catering to a diverse range of healthcare needs from generic pharmaceuticals to advanced medical devices.

Products and Services

Abbott Laboratories offers a comprehensive portfolio of products and services across various healthcare domains:

  • Generic Pharmaceuticals: Includes treatments for pancreatic exocrine insufficiency, irritable bowel syndrome, biliary spasm, intrahepatic cholestasis, depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease, vestibular vertigo, pain, fever, inflammation, migraine, anti-infective clarithromycin, influenza vaccine, and colon rhythm regulation products.
  • Diagnostic Products: Offers laboratory and transfusion medicine systems in areas such as immunoassay, clinical chemistry, hematology, and transfusion. Includes molecular diagnostics for DNA and RNA processing and detection of infectious agents, point-of-care systems, blood gas testing cartridges, rapid diagnostics, molecular point-of-care testing for several diseases, cardiometabolic tests, drug and alcohol tests, remote patient monitoring, consumer self-tests, and laboratory automation and informatics solutions.
  • Nutritional Products: Provides nutritional products for both pediatric and adult use, catering to the specific dietary needs of different age groups and health conditions.
  • Medical Devices: Offers a wide array of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, the company develops diabetes care products such as blood glucose monitoring systems, along with neuromodulation devices for managing chronic pain and movement disorders.

Contact Information

Address: 100 Abbott Park Road
Phone: 224 667 6100